Article
Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology - 1 Jan 2010
Joseph Kusumam, Tholanikunnel Tracy E, Kaplan Allen P
Abstract excerpt
BACKGROUND: Hereditary angioedema (HAE) is typically the result of a deficiency of C1 inhibitor (C1-INH) with gene defects that lead to diminished plasma levels or the production of a dysfunctional protein. Replacement therapy with C1-INH has been shown to be effective in ameliorating episodes of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.